#bioorthogonal ligation

Discover 2 curated intelligence briefings related to this specific topic.

Next-Gen Ligation Dictates ADC Industrial Viability
Science & Nature

Next-Gen Ligation Dictates ADC Industrial Viability

Industrial scale-up of Antibody-Drug Conjugates (ADCs) now demands a transition from random conjugation to site-specific bioorthogonal ligation. By integrating high-yield protein secretion platforms and multifunctional payloads like STING antagonists, manufacturers can stabilize the drug-to-antibody ratio (DAR) for complex bispecific architectures.

Read Analysis
Deep Tissue CRISPR Delivery Demands New Vector Logic
Technology & Innovation

Deep Tissue CRISPR Delivery Demands New Vector Logic

A technical guide on bypassing biological barriers in deep-tissue gene editing, utilizing AI-designed proteins, bioorthogonal ligation, and specialized viral vector manufacturing to achieve high-precision genomic modification.

Read Analysis